Hermetica Superfood Encyclopedia
The Short Answer
Oxygonum sinuatum aerial parts contain alkaloids, flavonoids, saponins, tannins, phenols, steroids, and terpenoids that mediate anti-inflammatory and analgesic effects, likely through pathways analogous to cyclooxygenase inhibition. Preclinical ethanolic extracts achieved 100% inhibition of egg albumin-induced paw edema and 87.8% inhibition of acetic acid-induced writhing in mice at 800 mg/kg, outcomes statistically comparable to diclofenac at 10 mg/kg.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordOxygonum sinuatum benefits
Oxygonum sinuatum — botanical close-up
Health Benefits
**Anti-Inflammatory Activity**
Ethanolic aerial extracts produced dose-dependent inhibition of experimentally induced paw edema in albino mice, reaching 100% inhibition at 800 mg/kg at four hours post-administration, mediated by flavonoids, tannins, and phenolic compounds that are presumed to suppress inflammatory mediators.
**Analgesic Effects**
The same ethanolic extract inhibited acetic acid-induced writhing by 87.8% at 800 mg/kg in mice, closely matching diclofenac's 87.3% inhibition, suggesting meaningful peripheral and possibly central pain-modulating activity attributable to its alkaloid and terpenoid content.
**Wound and Skin Condition Management**
Traditional Ugandan healers (who call the plant Kafumita bagenda) apply aerial parts to treat wounds, boils, and skin rashes, with tannins and saponins providing plausible astringent and antimicrobial mechanisms relevant to topical skin repair.
**Anti-Proliferative Potential**
In vitro studies report anti-proliferative activity against cancer cell lines attributed to the plant's phytochemical constituents, though specific cell lines, IC50 values, and responsible compounds remain uncharacterized in published literature.
**Angiogenesis Inhibition**
A zebrafish bioassay identified inhibition of angiogenesis by Oxygonum sinuatum extracts, suggesting potential interference with vascular endothelial growth factor (VEGF) signaling pathways, though the active compounds responsible have not been isolated or identified.
**Management of Tonsillitis and Upper Respiratory Inflammation**: Ugandan traditional medicine uses the aerial parts specifically for tonsillitis, consistent with the documented anti-inflammatory phytochemical profile including flavonoids and phenols known to reduce mucosal inflammation in related Polygonaceae species.
**Antimicrobial Support for Boils**
Saponins and tannins present in the extract provide a plausible mechanistic basis for the traditional use against boils and localized skin infections, as these compound classes disrupt microbial membranes and precipitate bacterial surface proteins.
Origin & History
Natural habitat
Oxygonum sinuatum is a flowering plant in the Polygonaceae family native to East Africa, particularly documented in Uganda where it grows in open bush and disturbed habitats. The plant is characterized by ovate-elliptic leaves up to 8×3 cm with three lobes and small flowers arranged in two-to-five-flowered clusters. It is not commercially cultivated and is harvested from wild populations by traditional healers.
“Oxygonum sinuatum holds a defined role in Ugandan traditional medicine, where it is known locally as Kafumita bagenda and used by traditional healers to treat pain, inflammation, tonsillitis, wounds, and boils. The aerial parts of the plant—leaves and stems—are the primary medicinal material, consistent with the documented phytochemical screening of these structures. The plant's use for skin conditions such as rashes and boils reflects a broader East African ethnobotanical tradition of using Polygonaceae family members for their astringent and anti-inflammatory properties, though formal ethnopharmacological surveys documenting preparation specifics and healer knowledge systems for this species remain sparse. No historical written records predating modern ethnobotanical surveys have been identified, and the knowledge of its use appears to be transmitted through oral traditional medical practice in Uganda.”Traditional Medicine
Scientific Research
The scientific evidence base for Oxygonum sinuatum is limited to a small number of preclinical studies and contains no published human clinical trials as of available literature. The most substantive pharmacological study used albino mice (n=20, divided into five groups of four animals each) to evaluate ethanolic aerial extract at doses of 200–800 mg/kg orally, demonstrating statistically significant (p<0.05) anti-inflammatory and analgesic effects compared to vehicle control and benchmarked against diclofenac 10 mg/kg. Anti-proliferative activity has been reported in in vitro cancer cell line assays and angiogenesis inhibition in a zebrafish bioassay, but neither study has been replicated or advanced to mechanistic characterization of active compounds. The overall evidence quality is very low by clinical standards due to small animal group sizes, absence of dose-response pharmacokinetic modeling, lack of toxicity profiling, and complete absence of human data.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (Presumed)**
Aerial parts (leaves, stems) boiled in water as a decoction for oral administration or topical application to wounds and boils; exact preparation ratios are unspecified in available ethnobotanical literature.
**Poultice (Presumed Traditional)**
Crushed fresh aerial parts applied directly to skin rashes, boils, and wounds; this form aligns with the plant's documented use for skin conditions in Ugandan traditional medicine.
**Ethanolic Extract (Research Form)**
200–800 mg/kg body weight in preclinical mouse studies; no human-equivalent dose has been established or validated
Aerial parts extracted with ethanol at a concentration yielding doses of .
**Standardization**
No commercial standardized extract exists; no marker compound percentages are defined for quality control purposes.
**Dose Translation Note**
800 mg/kg in mice does not directly translate to human doses without formal allometric scaling and safety studies; human dosing guidance cannot be responsibly provided based on current evidence
The preclinical effective dose of .
Nutritional Profile
Oxygonum sinuatum has not been analyzed for macronutrient or micronutrient composition in any published nutritional study, and no caloric, protein, fat, carbohydrate, vitamin, or mineral content data are available. Phytochemical screening of ethanolic aerial extracts confirms the presence of alkaloids, flavonoids, saponins, tannins, phenolic compounds, steroids, and terpenoids, consistent with the broad secondary metabolite profile typical of Polygonaceae family members. Specific compound concentrations (e.g., mg/g dry weight) have not been quantified for this species; flavonoid data reported for the unrelated Verbascum sinuatum (apigenin 5.85–13.82 µg/mg DW, luteolin 3.18–16.98 µg/mg DW) do not apply to Oxygonum sinuatum. Bioavailability parameters including oral absorption, first-pass metabolism, and tissue distribution for any constituent compound remain entirely unstudied.
How It Works
Mechanism of Action
The anti-inflammatory and analgesic activities of Oxygonum sinuatum are attributed to its complex phytochemical mixture—primarily flavonoids, tannins, phenols, alkaloids, saponins, steroids, and terpenoids—which collectively suppress pro-inflammatory mediator production through pathways not yet fully characterized at the molecular level. The degree of paw edema inhibition and writhing reduction observed in preclinical studies is pharmacodynamically comparable to diclofenac, suggesting possible modulation of arachidonic acid metabolism, including cyclooxygenase (COX-1/COX-2) enzyme inhibition, though direct enzyme binding data have not been reported for this species. Zebrafish bioassay data implicate VEGF pathway interference as a mechanism underlying the observed angiogenesis inhibition, pointing to potential anti-tumor and wound-remodeling activity that warrants further molecular investigation. Tannins and saponins present in the extract are known in related species to act through membrane disruption of microbial pathogens and modulation of nuclear factor kappa-B (NF-κB) inflammatory signaling, providing a plausible but unconfirmed mechanistic framework for the plant's traditional uses.
Clinical Evidence
No human clinical trials have been conducted on Oxygonum sinuatum for any indication, including its primary traditional use for skin conditions, pain, and inflammation. All quantitative outcome data derive from a single preclinical mouse study reporting 100% paw edema inhibition and 87.8% writhing inhibition at 800 mg/kg ethanolic extract, with statistical significance at p<0.05 but no effect size metrics such as Cohen's d reported. In vitro anti-proliferative and zebrafish angiogenesis assays provide exploratory mechanistic signals but cannot be translated into clinical dosing or efficacy claims. Confidence in the therapeutic use of this plant in humans is very low, and results should be interpreted solely as hypothesis-generating preclinical findings requiring validation in properly powered, controlled human studies.
Safety & Interactions
No formal safety or toxicology studies have been conducted on Oxygonum sinuatum in animals or humans, and acute, subacute, or chronic toxicity data are completely absent from the published literature. Traditional use in Uganda suggests some degree of tolerability at customary preparation doses, but this cannot substitute for rigorous safety evaluation, and no maximum safe dose has been established for any route of administration. Drug interactions have not been studied; however, given the likely presence of COX-modulating flavonoids and tannins—compound classes known in other species to interact with anticoagulants, NSAIDs, and hepatically metabolized drugs via CYP enzyme pathways—caution is warranted when co-administering any extract with prescription medications. Pregnant and lactating women, children, and immunocompromised individuals should avoid use entirely until safety data are available, and the plant should not be used as a substitute for evidence-based treatment of any medical condition.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Oxygonum sinuatumKafumita bagendaPolygonaceae East Africa herbSinuate oxygonum
Frequently Asked Questions
What is Oxygonum sinuatum used for traditionally?
In Ugandan traditional medicine, Oxygonum sinuatum (locally called Kafumita bagenda) is used by healers to treat pain, inflammation, tonsillitis, wounds, boils, and skin rashes. The aerial parts—leaves and stems—are the primary medicinal material, typically prepared as decoctions for internal use or poultices for topical skin application, though exact preparation methods are not formally documented in the scientific literature.
Is there scientific evidence that Oxygonum sinuatum works for skin conditions?
Direct clinical evidence for skin conditions is absent; however, preclinical studies support anti-inflammatory activity relevant to skin rashes and wound healing. A mouse study showed 100% inhibition of experimentally induced paw edema at 800 mg/kg ethanolic extract, and the plant's tannin and saponin content provides a mechanistic basis for astringent and antimicrobial effects on skin, though human trials have not been conducted.
What are the active compounds in Oxygonum sinuatum?
Phytochemical screening of ethanolic extracts from Oxygonum sinuatum aerial parts has identified alkaloids, flavonoids, saponins, tannins, phenolic compounds, steroids, and terpenoids. However, specific individual compounds have not been isolated and quantified for this species, and the identity of the primary active molecules responsible for its anti-inflammatory, analgesic, or anti-proliferative effects remains undetermined.
Is Oxygonum sinuatum safe to use?
The safety profile of Oxygonum sinuatum is unknown due to the complete absence of toxicology studies in either animals or humans. Traditional use in Uganda implies some level of tolerability, but no acute or chronic toxicity data, drug interaction studies, or contraindication assessments have been published. Until safety research is conducted, use by pregnant women, children, or individuals on prescription medications is not advisable.
What dose of Oxygonum sinuatum is effective?
No human-validated dose exists for Oxygonum sinuatum. Preclinical research used ethanolic aerial extract at 200–800 mg/kg body weight orally in mice, with the highest dose (800 mg/kg) achieving maximal anti-inflammatory and analgesic effects comparable to diclofenac 10 mg/kg. These animal doses cannot be directly converted to human equivalents without formal pharmacokinetic and safety studies, so no dosing recommendation can be responsibly made.
How does Oxygonum sinuatum compare to other anti-inflammatory herbs?
Oxygonum sinuatum demonstrates potent dose-dependent anti-inflammatory effects, with ethanolic extracts achieving complete inhibition of experimentally induced paw edema at 800 mg/kg. Its mechanism relies on flavonoids, tannins, and phenolic compounds that suppress inflammatory mediators, making it comparable to other polyphenol-rich herbs like turmeric or ginger in terms of phytochemical profile, though direct comparative clinical trials are limited.
What is the most effective form of Oxygonum sinuatum for reducing inflammation and pain?
Ethanolic extracts of Oxygonum sinuatum aerial parts have demonstrated superior efficacy in preclinical models, showing both anti-inflammatory and analgesic activity. The extraction method is critical because ethanol effectively solubilizes the active flavonoids, tannins, and phenolic compounds responsible for suppressing inflammatory mediators and pain responses.
Does the timing of Oxygonum sinuatum supplementation matter for its anti-inflammatory effects?
Preclinical studies indicate that Oxygonum sinuatum exhibits rapid anti-inflammatory activity, with maximum paw edema inhibition observed at four hours post-administration in animal models. While this suggests relatively quick onset, optimal timing in human supplementation may depend on individual factors such as digestion, food intake, and the specific inflammatory condition being addressed; more clinical research is needed to establish precise timing recommendations.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w oxygonum-sinuatum-oxygonum-sinuatum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
